skip navigation

Not in the United States?
change your preferences.

Neuropsychology and Substance Use

State-of-the-Art and Future Directions

• Edited by Ari Kalechstein, Wilfred G. van Gorp

Normal Price: $100.00

Our Web Price: $90.00add to cart

• Price: $100.00 $90.00
• Binding: Hardback
• Pages: 504
• Published by: Psychology Press
• Publication Date: 20th April 2007
• ISBN: 978-1-84169-457-3

About the Book

Substance use continues to be a major public health problem, and the ramifications of this are manifold. For instance, at present, on a yearly basis, the total economic cost of substance misuse is literally hundreds of billions of dollars. These costs are related to a number of factors, including, but not limited to, treatment and prevention, reduced job productivity and/or absenteeism, interdiction by the criminal justice, and incarceration.

There are many more psychosocial consequences of substance misuse, and these have been well–documented over the past four to five decades; in contrast, with the exception of alcohol, the effects of substance misuse on the brain have received attention only in the past 10 to 15 years. An emerging body of literature has reported on the effects of various drugs on neuropsychological functioning, including benzodiazepines, cocaine, marijuana, MDMA, methamphetamine, nicotine, and opioids. Despite the fact that the neuropsychological consequences of many drugs of abuse are well–documented, to our knowledge, no one had previously published an edited volume that focused exclusively on this issue. Based on this fact, we decided to create a volume that would review the available literature regarding on this topic.

Neuropsychology and Substance Misuse: State-of-the-Art and Future Directions explores cutting-edge issues, and will be of interest to clinical neuropsychologists who require the latest findings in this increasingly important area of neuropsychology.

Table of Contents

Kalechstein, van Gorp, Introduction. Maxwell, Finnerty, Rawson, Substance Abuse Epidemiology in the United States: A Review of the Indicator Data. Part I: Popular Drugs of Use. Oscar-Berman, Marinkovic, Alcohol. Crowe, Barker, Benzodiazepine. Bolla, Cadet, Cocaine. Gonzalez, Martin, Grant, Marijuana. Kalechstein, Fantegrossi, Cowan, MDMA. Kalechstein Newton, Methamphetamine. Belanger, Simmons, Schinka, Nicotine. Mintzer, Johnson, Opioid. Part II: Populations of Interest. Harwood, Sultzer, Substance Use and Neuropsychological Disorders in Aging. Basso, Bornstein, Ward, Neurobehavioral Consequences of Substance Abuse and HIV Infection. Tervo, The Neurocognitive Consequences of Substance Use in Schizophrenia: Are There Additive Effects? Part III: Future Directions. Monterosso, Kalechstein, Cordova, If Only the Hangover Preceded Intoxication: An Integration of Behavioral Economic and Neuropsychological Approaches to Impulsive Choice. Uslaner, Crombag, Robinson, The Influence of Environmental Context on the Effects of Drugs of Abuse.